Kreon

Pancreas Powder, the active ingredient in Kreon, is a pancreatic enzyme preparation presented as a powder for oral use. It treats exocrine pancreatic insufficiency in patients with cystic fibrosis, chronic pancreatitis, and related digestive disorders. GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kreon is a pancreatic enzyme preparation that supports digestion in conditions with impaired pancreatic function. - Exocrine pancreatic insufficiency: improves digestion of fats, proteins and carbohydrates in patients with insufficient pancreatic enzyme production. - Cystic fibrosis: provides necessary digestive enzymes to manage malabsorption associated with the disease. - Chronic pancreatitis: aids nutrient absorption by supplementing deficient pancreatic enzymes.

Kreon may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Abdominal discomfort or pain - Flatulence or gas - Oily or fatty stools (steatorrhea) - Nausea - Diarrhea - Constipation

Serious or Rare Side Effects: - Allergic reactions including rash, itching or swelling - Anaphylaxis (severe allergic response) - Severe abdominal pain or pancreatitis exacerbation - Intestinal obstruction or blockage - Severe hypocalcemia due to fat malabsorption

Before prescribing Kreon, clinicians should consider several safety measures. - Dose adjustment: individualize based on clinical response and dietary fat intake. - Monitoring: regularly assess nutritional status, weight gain and stool characteristics. - Contraindications: avoid in patients with known hypersensitivity to porcine-derived enzymes. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Drug interactions: be aware that antacids or proton‑pump inhibitors may reduce enzyme activity. - Store at room temperature below 25°C: keep in the original container, protect from moisture.

Kreon can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may inactivate pancreatic enzymes. - Proton‑pump inhibitors: can reduce enzyme activity by altering gastric pH. - Cholestyramine or other bile‑acid sequestrants: may bind enzymes and diminish effectiveness.

Moderate Interactions (Monitor Closely): - Oral corticosteroids: may increase risk of gastrointestinal irritation. - Broad‑spectrum antibiotics: alterations in gut flora could affect enzyme activity. - Warfarin: monitor INR as changes in fat absorption may influence vitamin K levels.